Pharmaceutical Excipients Reference Guide

Pharmaceutical excipients are no longer viewed as inert formulation components. They play a decisive role in drug product performance, manufacturability, stability, patient acceptability, and regulatory success. As dosage forms grow more complex and APIs present increasing challenges such as poor solubility, chemical instability, narrow therapeutic windows, or demanding delivery targets—the informed selection and application of excipients has become a core competency in pharmaceutical development.

Vitor Antraco compiled the PHARMACEUTICAL EXCIPIENTS – Complete Professional Reference Guide in February 2026

This Pharmaceutical Excipients – Complete Professional Reference Guide has been developed to support formulation scientists, development pharmacists, and pharmaceutical engineers with a structured, practice-oriented overview of excipients used across modern dosage forms. Covering approximately 400 excipients across 47 dosage forms, the guide bridges foundational excipient knowledge with real-world formulation considerations, reflecting how excipients are actually applied in development laboratories and manufacturing environments.

Rather than focusing solely on pharmacopeial definitions, this reference emphasizes functional roles, typical use levels, and formulation-relevant technical notes. Each excipient is contextualized within specific dosage forms ranging from conventional oral solids and liquids to modified-release systems, multiparticulates, lipid-based formulations, injectables, and advanced delivery platforms such as amorphous solid dispersions and liposomal products. Where relevant, considerations related to process selection, moisture sensitivity, compatibility risks, and performance trade-offs are highlighted.

The information presented is grounded in established pharmacopeial standards (USP–NF, Ph. Eur., JP), supplier technical documentation, and widely accepted industry references. Concentration ranges reflect typical reported values rather than absolute limits, recognizing that excipient selection and levels are inherently formulation-, process-, and region-dependent. Users are therefore encouraged to verify all data against current official monographs, supplier specifications, and applicable regulatory guidance prior to use in development or manufacturing.

This guide is intended as a practical decision-support tool, not a substitute for formulation development expertise or regulatory assessment. Its purpose is to accelerate early development thinking, support formulation screening, and provide a reliable reference framework when comparing excipient options across dosage forms and technologies.

By consolidating excipient knowledge in a dosage-form–driven structure, this reference aims to help development teams navigate the increasing complexity of pharmaceutical formulation—efficiently, scientifically, and with confidence.

If you are interested to receive the full listing, please compile the form below.